Capricor Therapeutics
CAPR
#6004
Rank
$1.14 B
Marketcap
$19.79
Share price
1.49%
Change (1 day)
215.63%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -$0.12 Billion USD

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$0.11 Billion USD a decrease over its 2024 earnings that were of -$40.47 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.12 Billion9.09%
2025 -$0.11 Billion159.57%
2024 -$40.47 Million81.57%
2023 -$22.29 Million-23.2%
2022 -$29.02 Million44.93%
2021 -$20.03 Million46.61%
2020 -$13.66 Million78.71%
2019 -$7.65 Million-49.7%
2018 -$15.2 Million-724.78%
2017 $2.43 M-112.93%
2016 -$18.81 Million46.27%
2015 -$12.86 Million106.82%
2014 -$6.22 Million-48.41%
2013 -$12.06 Million977.23%
2012 -$1.12 Million-77.11%
2011 -$4.89 Million-22.35%
2010 -$6.3 Million-20.17%
2009 -$7.89 Million-41.17%
2008 -$13.4 Million41.05%
2007 -$9.51 Million1098.87%
2006 -$0.8 Million4101.55%
2005 -$0.02 Million-0.97%
2004 -$0.02 Million17.87%
2003 -$0.02 Million3.66%
2002 -$0.02 Million-30.11%
2001 -$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$0.79 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-$0.83 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$0.31 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-$6.25 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-$14.92 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA